Buchumschlag

Low-density lipoprotein receptor-related protein 1 as a potential therapeutic target in Alzheimer’s disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease impacting the lives of millions of people worldwide. The formation of amyloid β (Aβ) plagues in the brain is the main pathological hallmark of AD. The Aβ deposits are formed due to the imbalance between the production and Aβ clearan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Petralla, Sabrina (VerfasserIn) , Panayotova, Maria (VerfasserIn) , Franchina, Elisa (VerfasserIn) , Fricker, Gert (VerfasserIn) , Puris, Elena (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 17 July 2024
In: Pharmaceutics
Year: 2024, Jahrgang: 16, Heft: 7, Pages: 1-21
ISSN:1999-4923
DOI:10.3390/pharmaceutics16070948
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/pharmaceutics16070948
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1999-4923/16/7/948
Volltext
Verfasserangaben:Sabrina Petralla, Maria Panayotova, Elisa Franchina, Gert Fricker and Elena Puris
Beschreibung
Zusammenfassung:Alzheimer’s disease (AD) is a progressive neurodegenerative disease impacting the lives of millions of people worldwide. The formation of amyloid β (Aβ) plagues in the brain is the main pathological hallmark of AD. The Aβ deposits are formed due to the imbalance between the production and Aβ clearance in the brain and across the blood-brain barrier (BBB). In this respect, low-density lipoprotein receptor-related protein 1 (LRP1) plays a significant role by mediating both brain Aβ production and clearance. Due to its important role in AD pathogenesis, LRP1 is considered an attractive drug target for AD therapies. In the present review, we summarize the current knowledge about the role of LRP1 in AD pathogenesis as well as recent findings on changes in LRP1 expression and function in AD. Finally, we discuss the advances in utilizing LRP1 as a drug target for AD treatments as well as future perspectives on LRP1 research.
Beschreibung:Gesehen am 19.11.2024
Beschreibung:Online Resource
ISSN:1999-4923
DOI:10.3390/pharmaceutics16070948

Ähnliche Einträge